SCHEMBL6902283

SCHEMBL6902283

CC(=O)NC(=O)CNc1ccc(O)c(O)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERCC1 P07992 4/20 0.56
ERCC4 Q92889 4/20 0.56
ARG1 P05089 1/20 0.46
ALDH1A1 P00352 3/20 0.41
MAPT P10636 2/20 0.41
KDM4E B2RXH2 1/20 0.41
LMNA P02545 1/20 0.41
HPGD P15428 1/20 0.41
PTGS1 P23219 1/20 0.41
BLM P54132 1/20 0.41
HIF1A Q16665 1/20 0.41
HSD17B10 Q99714 1/20 0.41
CA12 O43570 3/20 0.40
CA1 P00915 3/20 0.40
CA2 P00918 3/20 0.40
CA7 P43166 3/20 0.40
CA9 Q16790 2/20 0.40
CA14 Q9ULX7 2/20 0.40
POLB P06746 2/20 0.40
XDH P47989 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26292968 0.82 ERCC1 (0.54) ERCC1ERCC4ARG1ALDH1A1MAPT
SCHEMBL6905877 0.81 MAPT (0.52) ERCC1ERCC4ALDH1A1MAPTKDM4E
SCHEMBL6907026 0.79 ALDH1A1 (0.57) ALDH1A1MAPTLMNAHSD17B10POLB
SCHEMBL851008 0.77 ERCC1 (0.60) ERCC1ERCC4ARG1ALDH1A1MAPT
SCHEMBL6907362 0.76 ERCC1 (0.51) ERCC1ERCC4ARG1ALDH1A1CA12
SCHEMBL6909543 0.75 PKM (0.57) ERCC1ERCC4ALDH1A1MAPTKDM4E
SCHEMBL6906254 0.75 ERCC1 (0.54) ERCC1ERCC4ARG1ALDH1A1MAPT
Water SCHEMBL9710740 0.75 ERCC1 (0.58) ERCC1ERCC4ARG1ALDH1A1MAPT
SCHEMBL6906981 0.75 INSR (0.47) ALDH1A1MAPTKDM4ELMNAHPGD
Hydrochloric Acid SCHEMBL8166780 0.75 ERCC1 (0.50) ERCC1ERCC4ARG1ALDH1A1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6824786-B2 TOPICAL APPLYING COSMETIC YU RUEY J (US) 2004-11-30 US claimed
EP-1455734-A1 COMPOSITIONS COMPRISING PHENYL-GLYCINE DERIVATIVES Yu, Ruey J., Dr. (US) 2004-09-15 EP claimed
US-20030108496-A1 Compositions comprising phenyl-glycine derivatives YU RUEY J (US) 2003-06-12 US claimed
WO-2003045338-A1 COMPOSITIONS COMPRISING PHENYL-GLYCINE DERIVATIVES YU RUEY J (US) 2003-06-05 WO claimed
US-6824786-B2 TOPICAL APPLYING COSMETIC YU RUEY J (US) 2004-11-30 US disclosed
EP-1455734-A1 COMPOSITIONS COMPRISING PHENYL-GLYCINE DERIVATIVES Yu, Ruey J., Dr. (US) 2004-09-15 EP disclosed
US-20030108496-A1 Compositions comprising phenyl-glycine derivatives YU RUEY J (US) 2003-06-12 US disclosed
WO-2003045338-A1 COMPOSITIONS COMPRISING PHENYL-GLYCINE DERIVATIVES YU RUEY J (US) 2003-06-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030108496-A1 Compositions comprising phenyl-glycine derivatives GRHPR, ARL1, SUCLG1 ERCC1 3009/4885ERCC4 2755/4885ARG1 163/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.